Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13483399 | 0.88 | ALDH1A1 (0.47) | ALDH1A1PDE4BHSD11B1SMN1; SMN2NPC1 | |
| SCHEMBL29558577 | 0.88 | ALDH1A1 (0.48) | ALDH1A1PDE4BHSD11B1SMN1; SMN2NPC1 | |
| SCHEMBL951462 | 0.88 | SMN1; SMN2 (0.52) | ALDH1A1PDE4BHSD11B1SMN1; SMN2NPC1 | |
| SCHEMBL1762446 | 0.88 | ALDH1A1 (0.48) | ALDH1A1PDE4BHSD11B1SMN1; SMN2NPC1 | |
| SCHEMBL45159 | 0.88 | ALDH1A1 (0.44) | ALDH1A1PDE4BHSD11B1SMN1; SMN2NPC1 | |
| SCHEMBL29860005 | 0.87 | ALDH1A1 (0.47) | ALDH1A1PDE4BHSD11B1SMN1; SMN2NPC1 | |
| SCHEMBL950958 | 0.87 | ALDH1A1 (0.47) | ALDH1A1PDE4BHSD11B1SMN1; SMN2NPC1 | |
| SCHEMBL30234226 | 0.86 | ALDH1A1 (0.47) | ALDH1A1PDE4BHSD11B1SMN1; SMN2NPC1 | |
| SCHEMBL1762554 | 0.86 | ALDH1A1 (0.47) | ALDH1A1PDE4BHSD11B1SMN1; SMN2NPC1 | |
| SCHEMBL29372796 | 0.86 | ALDH1A1 (0.47) | ALDH1A1PDE4BHSD11B1SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2582688-B1 | ANTHRANILIC ACID DIAMIDE DERIVATIVES | BAYER IP GMBH (DE) | 2015-10-07 | — | — | EP | disclosed |
| US-8791139-B2 | Anthranilic diamide derivatives | BAYER CROPSCIENCE AG (DE) | 2014-07-29 | — | — | US | disclosed |
| EP-2582688-A1 | ANTHRANILIC ACID DIAMIDE DERIVATIVES | Bayer Intellectual Property GmbH (DE) | 2013-04-24 | — | — | EP | disclosed |
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-01-19 | — | — | US | disclosed |
| WO-2011157654-A1 | ANTHRANILIC ACID DIAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2011-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | DDT, QDPR, ANTXR2 | ALDH1A1 732/4885PDE4B 132/4885HSD11B1 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.